Thayumanavan, Minter Focus on Drug Delivery System for Rheumatoid Arthritis

Both M2M and CBD researchers, organic and polymer chemist Thai Thayumanavan and professor of animal science Lisa Minter, have partnered with Anika Therapeutics Inc. of Bedford to co-develop a new product for treating the autoimmune disease rheumatoid arthritis.

The work is part of Phase II of a continuing relationship between IALS and Anika.

Thayumanavan and Minter say this next phase of the collaboration builds on Thayumanavan’s expertise in delivering molecules into cells in a targeted and specific way and Minter’s expertise in autoimmune disease. They and the company will focus on research to optimize a drug delivery system to advance a new therapy candidate.